You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Extended Abstract
  • Open Access

27 August 2019

Synthesis of Polyfluorinated KRN7000 Analogues and Biological Implications †

,
,
,
,
and
Analytical Chemistry and Organic Chemistry Department, Faculty of Chemistry, Sescelades Campus, University Rovira i Virgili, 43002 Tarragona, Spain
*
Author to whom correspondence should be addressed.
Presented at the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery, Barcelona, Spain, 15–17 May 2019.
This article belongs to the Proceedings The 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery
KRN7000 is a synthetic glycosphingolipid developed as an anticancer drug candidate, which upon association with the CD1d protein activates NKT cells. This event leads to the release of different cytokines, which modulate a TH1 response (antitumoral and antimicrobial functions) or a TH2 response (against autoimmune diseases). Unfortunately, the simultaneous secretion of both cytokines limits the therapeutic potential of KRN7000, as they can antagonize the biological functions of each type alone. For that reason, the synthesis of new KRN7000 analogues with a more biased TH1/TH2 profile is an area of special interest [1].
It has been suggested that TH1 response is certainly favoured by stabilization of the KRN7000–CD1d–NKT complex [2]. In this regard, it has been recently demonstrated that perfluorinated chains produce stronger interactions with hydrophobic cavities of proteins than its hydrocarbon counterparts [3].
In this communication, we will report the synthesis of set of KRN7000 analogues bearing different perfluoroalkyl chains at the ceramide moiety, with the aim of increasing the stability of the complex to obtain a selective TH1 response. Biological implications based on binding affinity towards mouse CD1d protein as well as mouse and human iNKT cell stimulation experiments will also be discussed.

Acknowledgments

Financial support: Ministerio de Economia y Competividad, Spain (Project CTQ2017-89750-R and CTQ2014-58664-R), Universitat Rovira i Virgili for a grant (D.C., Martí Franquès program, Ref: 2012BPURV-16), Ramón y Cajal contract (RYC-2015-17705 to O.B.).

References

  1. East, J.E.; Kennedy, A.J.; Webb, T.J. Raising the Roof: The Preferential Pharmacological Stimulation of Th1 and Th2 Responses Mediated by NKT Cells. Med. Res. Rev. 2014, 34, 45–76. [Google Scholar] [CrossRef] [PubMed]
  2. Laurent, X.; Bertin, B.; Renault, N.; Farce, A.; Speca, S.; Milhomme, O.; Millet, R.; Desreumaux, P.; Hénon, E.; Chavatte, P. Switching Invariant Natural Killer t (iNKT) Cell Response from Anticancerous to Anti-Inflammatory Effect: Molecular Bases. J. Med. Chem. 2014, 57, 5489–5508. [Google Scholar] [CrossRef] [PubMed]
  3. Liu, L.; Jalili, N.; Baergen, A.; Ng, S.; Bailey, J.; Derda, R.; Klassen, J.S. Fluorine Bonding Enhances the Energetics of Protein-Lipid Binding in the Gas Phase. J. Am. Soc. Mass Spectrom. 2014, 25, 751–757. [Google Scholar] [CrossRef]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.